Medtronic is nearing a U.S. launch for its Hugo surgical robot more than three years after receiving approval to release the soft tissue system in Europe. CEO Geoff Martha told investors Tuesday ...

Discover why Intuitive Surgical's monopoly-like position is under threat from emerging competitors like Medtronic and J&J.

Medtronic ( MDT -0.99%) and Abbott Laboratories ( ABT -1.91%) are two such examples in the healthcare industry. Both are ...

Medtronic is making major moves with its Hugo surgical robot platform to submit for the FDA approval in 2025. MDT currently trails Intuitive Surgical in this niche, but the roll-out of the Hugo ...

Intuitive remains the dominant surgical robotics company — but other companies with savvy strategies are generating buzz and ...

Medtronic's Q3 adjusted EPS of $1.39 surpassed ... driven by innovations such as the HUGO Robotic Platform and Renal Denervation.

the Hugo System, for an area that remains deeply underpenetrated. Both of these niches could represent powerful, long-term tailwinds for the company. Furthermore, Medtronic is implementing ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Charles Schwab Corp., Gilead ...

The company has expressed expectations of a revenue and EPS growth acceleration in the fourth quarter, driven by innovations like the HUGO Robotic Platform and Renal Denervation. These developments ...